Read + Share
Amedeo Smart
Independent Medical Education
Sato K, Babazono T. Successful Withdrawal of Erythropoiesis-stimulating Agent after Administration of an SGLT2 Inhibitor, Tofogliflozin, in People with Diabetes. Diabet Med 2021 Jul 3:e14632. doi: 10.1111/dme.14632.PMID: 34216511
Email
LinkedIn
Facebook
Twitter
Privacy Policy